Individual Investigator Research Awards
- Supports applications for innovative research projects addressing critically important questions that will significantly advance knowledge of the causes, prevention, and/or treatment of cancer. Areas of interest include laboratory research, translational studies, and/or clinical investigations. Competitive renewal applications accepted. Award: Up to $350,000 per year. Exceptions permitted if extremely well justified; maximum duration: 3 years.
Individual Investigator Research Awards for Cancer in Children and Adolescents
- Supports applications for innovative research projects addressing questions that will advance knowledge of the causes, prevention, progression, detection, or treatment of cancer in children and adolescents. Laboratory, clinical, or population-based studies are all acceptable. CPRIT expects the outcome of the research to reduce the incidence, morbidity, or mortality from cancer in children and/or adolescents in the near or long term. Competitive renewal applications accepted. Award: Up to $350,000 per year. Applicants that plan on conducting a clinical trial as part of the project may request up to $500,000 in total costs. Exceptions permitted if extremely well justified; maximum duration: 4 years.
Individual Investigator Research Awards for Clinical Translation
- Supports applications that propose innovative cancer clinical studies that are hypothesis driven and involve patients enrolled prospectively on a clinical trial. Areas of interest include clinical studies of new or repurposed drugs, hormonal therapies, immune therapies, surgery, radiation therapy, stem cell transplantation, combinations of interventions, or therapeutic devices. Award: Up to $500,000 per year. Maximum duration: 4 years. Exceptions permitted if extremely well justified.
Individual Investigator Research Awards for Computational Systems Biology of Cancer
- Supports applications for innovative mathematical and/or computational research projects addressing questions that will advance current knowledge in the (a) mechanisms that tie altered gene expression and downstream molecular mechanisms to functional cancer phenotypes and/or (b) mechanisms that tie tumor morphology to functional cancer phenotypes and/or mechanisms that tie treatment sequence and combination to evolving functional cancer phenotypes (that emerge as a result of treatment selection). Award: Up to $400,000 in total costs per year for up to 4 years. Exceptions permitted if extremely well justified.
Individual Investigator Research Awards for Prevention and Early Detection
- Supports applications which propose clinical and population-based projects designed to develop effective prevention and early detection interventions to reduce cancer risk, mortality, and morbidity among Texans. Projects that propose such research collaborations with existing CPRIT Prevention Program awardees including the CPRIT funded Texas Collaborative Center for Hepatocellular Cancer (https://www.bcm.edu/research/labs-and-centers/research-centers/texas-collaborative-center-for-hepatocellular-cancer) are strongly encouraged. Award: Up to $400,000 per year. Exceptions permitted if extremely well justified; maximum duration: 5 years.
Texas Regional Excellence in Cancer Award
- Solicits applications to strengthen cancer research at institutions located in regions of Texas that have historically received low levels of peer reviewed cancer research funding. This mechanism is open to Texas institutions whose campus is located > 100 mi from an NCI Designated Cancer Center. The award will support an established investigator to lead a program with a cohesive theme relevant to the cancer problems of the region and 3 to 5 research projects. In addition, funds maybe requested to support recruitment of new junior faculty, shared resources, and partnerships with established Texas cancer research programs to provide mentorship and access to facilities or expertise. Award: Up to $6,000,000 (total costs); Maximum duration: 5 years.